查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1943474

经经皮二氧化碳监测市场按产品类型、技术、年龄层、应用和最终用户分類的全球预测（2026-2032年）

Transcutaneous CO2 Monitoring Market by Product Type, Technology, Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，经皮二氧化碳监测市场价值将达到 23.3 亿美元，到 2026 年将成长至 25.4 亿美元，到 2032 年将达到 40.6 亿美元，复合年增长率为 8.21%。

关键市场统计数据
基准年 2025 23.3亿美元
预计年份：2026年 25.4亿美元
预测年份 2032 40.6亿美元
复合年增长率 (%) 8.21%

权威概述了连续非侵入性经皮二氧化碳监测如何改变各种医疗保健环境中的呼吸照护路径和临床决策。

经皮二氧化碳监测正在迅速改变呼吸系统和重症监护的诊疗路径，它能够在床边及其他场所实现对二氧化碳变化趋势的连续、非侵入性评估。临床医生越来越依赖可靠的经皮感测器来补充动脉和毛细血管血气分析，尤其是在连续有创采样不切实际或风险较高的情况下。在包括门诊手术中心、家庭护理和重症监护医院在内的越来越多的医疗服务场所，无需重复穿刺即可获得连续二氧化碳数据的能力有助于改善临床决策，支持通讯协定的通气管理，并改善镇静和康復期间的监测。

感测器小型化、远端医疗整合和数据分析相结合，将经皮二氧化碳监测的应用范围扩展到了传统急性护理之外。

在技​​术成熟、医疗服务模式演变和数据驱动型临床实践的推动下，经经皮二氧化碳监测领域正在发生多项变革性变化，重塑其格局。首先，小型化和感测器技术的创新加速了携带式手持设备和超薄探头的研发，使得监测范围不再局限于加护病房和居家医疗等其他医疗环境。因此，临床医生能够持续追踪患者的通气状态，这在以往的心肺復健、门诊监测和术后恢復期间是难以实现的。

评估2025年美国关税调整对经皮二氧化碳监测设备製造商的零件采购、定价策略和供应链韧性的影响

2025年生效的关税调整对美国医疗设备供应链的累积影响，将对经皮二氧化碳监测系统的製造商和采购商带来即时的营运挑战和长期的策略影响。关税可能增加进口零件（例如感测器膜、电子模组和光学元件）的到岸成本，迫使原始设备製造商 (OEM) 重新评估其筹资策略，并在采购惯例中增强抵御关税衝击的能力。为此，许多设备製造商正在调整材料清单(BOM) 策略，在低关税地区寻找替代供应商，或加速本地组装以降低进口关税风险。

综合細項分析揭示了最终用户环境、患者年龄、技术类型、临床应用和产品形式如何相互作用，从而影响设备需求。

经皮二氧化碳监测市场的细緻细分突显了临床需求、设备外形和技术选择相互交织，从而形成差异化需求。分析终端使用者可知，门诊手术中心需要针对快速设定和术中监测进行最佳化的设备。同时，诊所包括注重常规评估的全科诊所和需要高精度监测以应用于呼吸和睡眠医学领域的专科诊所。居家医疗分为两类：上门护理服务优先考虑功能强大且易于使用的监测器，而远端监测服务则优先考虑安全的资料传输和使用者友善的介面。医院内部的需求各不相同，二级医疗机构优先考虑成本效益和工作流程整合，而三级医疗机构则需要适用于复杂重症监护和手术全期环境的高级功能。

报销模式、基础设施成熟度和本地生产等因素影响着主要全球市场的采用路径，区域趋势的比较分析也印证了这一点。

区域趋势在经皮二氧化碳监测技术的应用和商业化过程中发挥着至关重要的作用，每个主要区域都存在不同的驱动因素和限制因素。在美洲，成熟的医院系统以及不断扩展的门诊和居家医疗服务推动了对高端主机和携带式手持设备的需求。报销机制和大规模采购计画影响着采购週期，而完善的服务基础设施则为设备的长期维护和培训提供了支援。欧洲、中东和非洲地区的情况则较为复杂，有些国家拥有先进的三级医疗中心，而有些国家则资源有限，这使得对高端光学解决方案和经济高效的电化学解决方案的需求都日益增长。监管协调工作和跨区域报销倡议会影响设备的审批时间和跨境分销策略。

在连续二氧化碳监测领域，策略性产业趋势和能力投资如何区分市场领导、新参与企业和生态系统合作伙伴。

为了确保临床应用和商业性可行性，经经皮二氧化碳监测领域的企业正在采取多种策略，从专注于产品创新到建立生态系统伙伴关係。成熟的医疗设备製造商正致力于改进感测器化学成分和校准演算法，以提高精度并降低维护成本。同时，新参与企业则专注于便携性、简化的使用者介面以及云端远端监测，以抢占门诊和居家医疗市场。设备製造商、软体供应商和临床网路之间的策略联盟，正在实现与电子健康记录和远端监测平台的无缝数据集成，从而提升多学科医疗团队对持续二氧化碳监测的效用。

为製造商和供应商提供切实可行的高影响力措施，以加速监测解决方案的采用，降低供应风险，并展现其临床和经济价值。

在瞬息万变的商业环境中，产业领导者应采取一系列切实有效且影响深远的措施，以加速技术应用并保障利润率。製造商应优先考虑与电子健康记录和远端监测平台的互通性和无缝资料交换，使连续二氧化碳资料成为临床互通性中可利用的一部分，而非孤立的资料流。同时，投资于完善的售后服务，例如远端校准、技术人员认证和临床培训，将有助于减少设备停机时间，并提升医院采购团队对设备价值的认知。

为了确保研究结果的可靠性和实际相关性，我们采用了一种透明、多方面的研究途径，结合了临床医生访谈、设备文件和技术检验。

本研究采用结构化的调查方法，整合了多种证据来源，以确保分析的严谨性和实用性。主要研究包括对新生儿、儿童和成人重症监护室的临床医生、医院和门诊手术中心的采购人员以及参与设备整合和远端监测操作的技术专家进行深度访谈。次要研究整合了同行评审的临床研究、设备监管文件、临床实践指南和已发布的技术规范，以检验设备的性能特征和临床应用案例。

本文简要概述了为何整合技术、临床证据和稳健的商业策略对于连续经皮二氧化碳监测的广泛应用至关重要。

总之，经皮二氧化碳监测正处于一个转折点，技术的成熟、多样化的医疗服务模式以及数据驱动的临床工作流程的整合，将推动其在所有医疗环境中发挥更广泛的作用。兼具准确性、易用性和连接性的设备将透过在新生儿病房、重症监护室、门诊和居家照护中实现连续呼吸监测，从而最大限度地发挥其临床价值。电化学和光学技术的融合正在创造出丰富的产品选择，这些产品可根据特定临床领域进行定制，从对成本敏感的二级医疗中心到高度紧急的三级医疗中心均可适用。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 经经皮二氧化碳监测市场（依产品类型划分）

  • 监控主机
  • 携带式设备
  • 感测器探头

第九经皮经皮二氧化碳监测市场（依技术划分）

  • 电化学公式
  • 光学的

第十经皮依年龄组别分類的经皮二氧化碳监测市场

  • 成人
  • 新生
  • 儿童

第十一章 经经皮二氧化碳监测市场（依应用领域划分）

  • 门诊监测
    • 心肺復健
    • 门诊监测
  • 重症监护
    • 成人重症监护
    • 新生儿重症监护
    • 儿童重症监护
  • 新生儿护理
    • 早产儿护理
    • 足月新生儿护理
  • 呼吸护理
    • 急性呼吸护理
    • 慢性呼吸护理

第十二章 经经皮二氧化碳监测市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
    • 一般诊所
    • 专科诊所
  • 居家医疗
    • 居家照护服务
    • 远端监控服务
  • 医院
    • 二级护理医院
    • 三级医院

第十三章 经经皮二氧化碳监测市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章经皮二氧化碳监测市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五经皮各国经皮二氧化碳监测市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国经皮二氧化碳监测市场

第十七章：中国经皮二氧化碳监测市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Dragerwerk AG & Co. KGaA
  • General Electric Company
  • Koninklijke Philips NV
  • Laike Biotechnology Co., Ltd.
  • Masimo Corporation
  • Medicap GmbH
  • Medtronic plc
  • Mindray DS USA, Inc.
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Perimed AB
  • Philips Healthcare
  • Qiumanshi Medical Technology Co., Ltd.
  • Radiometer A/S
  • Sentec AG
  • Shinsei Electronics Corporation
  • Smiths Group plc
  • Welch Allyn Inc.
Product Code: MRR-F847BD9C7378

The Transcutaneous CO2 Monitoring Market was valued at USD 2.33 billion in 2025 and is projected to grow to USD 2.54 billion in 2026, with a CAGR of 8.21%, reaching USD 4.06 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.33 billion
Estimated Year [2026] USD 2.54 billion
Forecast Year [2032] USD 4.06 billion
CAGR (%) 8.21%

An authoritative overview of how continuous noninvasive transcutaneous CO2 monitoring is changing respiratory care pathways and clinical decision-making across settings

Transcutaneous CO2 monitoring is rapidly reshaping respiratory and critical care pathways by enabling continuous, noninvasive assessment of carbon dioxide trends at the bedside and beyond. Clinicians increasingly rely on reliable transcutaneous sensors to complement arterial and capillary measurements, especially when serial invasive sampling is impractical or poses risk. As healthcare delivery diversifies across ambulatory surgery centers, home settings, and high-acuity hospitals, the capability to obtain continuous CO2 data without repeated punctures enhances clinical decision-making, supports protocolized ventilation management, and improves monitoring during sedation and rehabilitation.

The integration of portable handheld devices and sensor probes alongside conventional monitor consoles affords care teams greater flexibility in deploying monitoring where it is most needed. Concurrently, improvements in sensor chemistry, signal processing algorithms, and device ergonomics are reducing calibration burdens and increasing measurement stability across patient populations from neonates to adults. These advances, paired with evolving clinical guidelines that emphasize early detection of ventilatory compromise, are repositioning transcutaneous CO2 monitoring from a niche adjunct to a mainstream component of respiratory care pathways.

Looking ahead, the field will continue to be shaped by interoperability requirements, reimbursement clarity, and evidence that demonstrates patient-centered benefits. Clinicians and procurement leaders should therefore consider not only the technical performance of devices but also integration into care workflows, remote monitoring capabilities, and training programs that ensure reliable capture and interpretation of transcutaneous CO2 data.

How sensor miniaturization, remote care integration, and data analytics are converging to expand continuous transcutaneous CO2 monitoring beyond traditional acute care

Several transformative shifts are redefining the landscape of transcutaneous CO2 monitoring, driven by technology maturation, care delivery evolution, and data-driven clinical practice. First, miniaturization and sensor innovation have accelerated the development of portable handheld units and low-profile probes that expand monitoring beyond intensive care units into ambulatory monitoring and home healthcare environments. As a result, clinicians can track ventilatory status during cardiopulmonary rehabilitation, outpatient monitoring, and post-procedural recovery with a continuity that was previously difficult to achieve.

Second, telemonitoring and remote care models are integrating continuous physiologic inputs into virtual care pathways, enabling earlier detection of respiratory deterioration and smoother transitions from hospital to home. Third, the adoption curve for advanced monitoring is being supported by improvements in optical and electrochemical technologies that offer complementary trade-offs: optical methods often provide faster response and longer-term stability while electrochemical approaches deliver cost-effective solutions suitable for disposable or semi-disposable probes. These technical differences are influencing procurement decisions and clinical training priorities.

Finally, the convergence of data analytics, device interoperability, and clinical protocols is producing higher-value outputs from continuous CO2 traces. Predictive analytics and trend-based alerts are moving from experimental to operational status, helping care teams act on subtle physiology changes before overt clinical decline. Collectively, these shifts are expanding the clinical utility of transcutaneous CO2 monitoring and redefining expectations for continuous respiratory surveillance across the care continuum.

Assessing how 2025 US tariff adjustments are reshaping component sourcing, pricing strategies, and supply resilience for transcutaneous CO2 monitoring device manufacturers

The cumulative impact of tariff changes on medical device supply chains in the United States during 2025 introduces both immediate operational challenges and longer-term strategic repercussions for manufacturers and buyers of transcutaneous CO2 monitoring systems. Tariffs can increase landed costs for imported components such as sensor membranes, electronic modules, and optical elements, prompting original equipment manufacturers to evaluate sourcing strategies and build resilience into procurement practices. In response, many device makers are adjusting bill-of-materials strategies, seeking alternative suppliers in lower-tariff jurisdictions, or accelerating localization of assembly to reduce exposure to import duties.

For distributors and healthcare purchasers, tariff-driven cost pressure is influencing contract negotiations, total cost of ownership assessments, and capital allocation decisions. Procurement teams are under renewed scrutiny to justify purchases by demonstrating clinical value and lifecycle costs, including maintenance and consumable replacement. Meanwhile, research and development timelines may be affected as companies balance investment in next-generation optical or electrochemical sensor platforms with the need to protect margin under shifting trade conditions.

Importantly, tariff impacts extend beyond direct cost increases; they alter supplier competitiveness and can catalyze consolidation as smaller manufacturers struggle with margin compression. Stakeholders should therefore undertake scenario planning that considers alternative sourcing, multi-tier supplier relationships, and the potential for strategic partnerships that mitigate tariff exposure while preserving supply continuity and product innovation.

Integrative segmentation analysis revealing how end-user environments, patient age, technology types, clinical applications, and product formats interact to shape device requirements

Nuanced segmentation of the transcutaneous CO2 monitoring market provides clarity on where clinical demand, device form factors, and technology choices intersect to create differentiated needs. When examining end users, ambulatory surgery centers require devices optimized for rapid setup and procedure-level monitoring, while clinics encompass both general clinics that focus on routine assessment and specialty clinics that demand higher precision for pulmonary and sleep medicine applications. Home healthcare splits into home nursing services that prioritize robust, easy-to-use monitors and telemonitoring services that emphasize secure data transmission and user-friendly interfaces. Hospitals present a spectrum of requirements with secondary care hospitals prioritizing cost-effectiveness and workflow integration, and tertiary care hospitals seeking advanced features suitable for complex critical care and perioperative environments.

Age-based segmentation further refines device selection and clinical protocols, as adults, pediatrics, and neonates present different physiologic ranges, skin properties, and size constraints that influence sensor design and calibration needs. Technology segmentation, divided between electrochemical and optical approaches, highlights trade-offs in response time, calibration frequency, and consumable usage, which in turn affects procurement of monitor consoles, portable handheld devices, and sensor probes. Application-driven segmentation reveals that ambulatory monitoring includes cardiopulmonary rehabilitation and outpatient monitoring contexts where mobility and ease of use are paramount, while intensive care spans adult, neonatal, and pediatric intensive care settings that demand high-fidelity continuous measurements. Neonatal care itself splits into preterm and term neonatal care with specialized probe designs and gentle adhesive systems, and respiratory care includes acute and chronic pathways where trending capability and alarm integration are critical.

Product-type segmentation clarifies that monitor consoles typically serve centralized monitoring in hospitals, portable handheld devices support point-of-care and home settings, and sensor probes function as both disposable and reusable interfaces that determine recurring supply chain dynamics. Taken together, these segmentation layers inform clinical adoption strategies, regulatory focus, and go-to-market approaches by aligning device attributes with the operational realities and clinical endpoints of each subsegment.

Comparative regional dynamics showing how reimbursement models, infrastructure maturity, and local manufacturing shape adoption pathways across major global markets

Regional dynamics play a determinative role in how transcutaneous CO2 monitoring technologies are adopted and commercialized, with each major geography exhibiting distinct drivers and constraints. In the Americas, established hospital systems and growing outpatient and home care services drive demand for both high-end monitor consoles and portable handheld devices; reimbursement frameworks and large-scale procurement programs shape purchasing cycles while a strong service infrastructure supports long-term device maintenance and training. Europe, the Middle East & Africa presents a heterogeneous landscape where advanced tertiary centers in some countries coexist with resource-constrained facilities elsewhere, creating demand for both premium optical solutions and cost-effective electrochemical options. Regulatory harmonization efforts and pan-regional reimbursement initiatives influence device certification timelines and cross-border distribution strategies.

Asia-Pacific encompasses rapidly expanding healthcare capacity, rising investments in neonatal and critical care, and a surge in telemonitoring deployments that favor portable form factors and integrated data platforms. Local manufacturing hubs and component suppliers in this region offer opportunities for cost optimization and faster time-to-market, but also introduce competitive pressures from nimble regional entrants. Across all regions, clinical evidence generation, interoperability standards, and training programs are pivotal to scaling adoption. Stakeholders should therefore tailor commercial models to regional reimbursement structures, procurement behaviors, and clinical needs while maintaining a unified product narrative that emphasizes patient safety, usability, and data integrity.

Strategic industry maneuvers and capability investments that distinguish market leaders, new entrants, and ecosystem partners in continuous CO2 monitoring

Companies operating in the transcutaneous CO2 monitoring space are pursuing a mix of strategies to secure clinical adoption and commercial viability, ranging from focused product innovation to ecosystem partnerships. Several established medical device firms are investing in incremental improvements to sensor chemistry and calibration algorithms to enhance accuracy and reduce maintenance burden, while newer entrants are targeting portability, user interface simplicity, and cloud-enabled telemonitoring to capture outpatient and home healthcare segments. Strategic partnerships between device manufacturers, software vendors, and clinical networks are enabling more seamless data integration with electronic health records and remote monitoring platforms, thereby increasing the utility of continuous CO2 traces for multidisciplinary care teams.

Manufacturers are also optimizing product portfolios by differentiating between monitor consoles for high-acuity settings and portable handheld units for ambulatory and home use, with sensor probes designed as either reusable modules for hospitals or single-use consumables for infection control and convenience. Supply chain strategies focus on supplier diversification and vertical integration of critical components to protect against geopolitical and tariff-related disruptions. Additionally, companies are expanding into value-added services such as training, remote calibration, and clinical decision-support algorithms to enhance stickiness with healthcare customers and create recurring revenue streams.

From a competitive standpoint, firms that combine clinical evidence generation, regulatory expertise, and scalable service models are best positioned to win tenders and form long-term relationships with health systems. Corporate strategies that emphasize interoperability, user-centered design, and lifecycle support will likely determine leadership in this evolving market.

High-impact, actionable steps for manufacturers and providers to drive adoption, reduce supply risk, and demonstrate clinical and economic value for monitoring solutions

Industry leaders should adopt a set of practical, high-impact measures to accelerate adoption and protect margin in a rapidly changing commercial environment. Manufacturers must prioritize interoperability and seamless data exchange with electronic health records and telemonitoring platforms to ensure that continuous CO2 data become an actionable part of clinical workflows rather than an isolated data stream. Concurrently, investing in robust post-sales services such as remote calibration, technician certification, and clinically oriented training will reduce device downtime and increase perceived value among hospital procurement teams.

On the sourcing front, firms should implement multi-sourcing strategies for critical components and evaluate regional assembly to mitigate tariff exposure and supply chain disruption. Product roadmaps should balance innovation in optical and electrochemical sensing with cost-conscious probe designs that address both disposable and reusable use cases. For market access, building a compelling clinical evidence base through targeted multi-center studies in neonatal and intensive care units, and real-world validation in ambulatory and home settings, will support reimbursement discussions and clinician acceptance. Finally, commercial teams should segment go-to-market approaches by end user and application, aligning sales incentives and training materials to the unique priorities of ambulatory surgery centers, clinics, home healthcare providers, and different hospital tiers.

By executing on interoperability, supply resilience, evidence generation, and service excellence, industry leaders can convert technological capability into sustainable clinical adoption and commercial returns.

A transparent, multi-source research approach combining clinician interviews, device documentation, and technical validation to ensure reliable insights and practical relevance

This research synthesized multiple sources of evidence and applied a structured methodology to ensure analytical rigor and practical relevance. Primary research included in-depth interviews with clinicians across neonatal, pediatric, and adult intensive care settings, procurement leaders from hospitals and ambulatory surgery centers, and technical specialists involved in device integration and telemonitoring operations. Secondary research incorporated peer-reviewed clinical studies, device regulatory documents, clinical practice guidelines, and publicly available technical specifications to validate performance characteristics and clinical use cases.

Data triangulation was achieved by cross-referencing qualitative insights with device performance literature and supplier disclosures, enabling a balanced view of technology trade-offs and operational implications. The analysis also incorporated an assessment of supply chain exposures, tariff scenarios, and commercial strategies obtained through interviews with industry supply chain managers and commercial leaders. Quality assurance steps involved expert review by clinical informaticians and biomedical engineers to confirm technical accuracy, and an editorial review to ensure clarity and consistency.

Limitations of the methodology include variability in data availability across regions and the evolving nature of regulatory guidance and reimbursement policies. To mitigate these constraints, the study prioritized primary stakeholder perspectives and recent clinical evidence, and employed sensitivity checks to ensure that conclusions remain robust against plausible variations in external conditions.

A concise synthesis of why integrated technology, clinical evidence, and resilient commercial strategies are essential to scale continuous transcutaneous CO2 monitoring

In summary, transcutaneous CO2 monitoring stands at an inflection point where technical maturity, diversified care delivery models, and data-enabled clinical workflows converge to expand its role across care settings. Devices that balance accuracy, ease of use, and connectivity will unlock the greatest clinical value by enabling continuous respiratory surveillance in neonatal units, intensive care environments, ambulatory contexts, and home-based care. The interplay between electrochemical and optical technologies creates a spectrum of product choices that manufacturers can tailor to specific clinical segments, from cost-sensitive secondary hospitals to high-acuity tertiary centers.

Strategic considerations such as tariff management, supplier diversification, and evidence-based market access planning are critical to sustaining innovation and commercial viability. Companies that integrate robust service offerings, prioritize interoperability, and invest in targeted clinical validation will be better positioned to influence purchasing decisions and clinician adoption. Ultimately, the pathway to wider adoption requires coordinated efforts across R&D, regulatory, clinical, and commercial functions to translate continuous CO2 signals into improved patient outcomes and operational efficiencies.

Decision-makers should therefore treat transcutaneous CO2 monitoring as a strategic capability rather than a discrete product purchase, aligning technology choices with clinical protocols, workforce competencies, and long-term care delivery goals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Transcutaneous CO2 Monitoring Market, by Product Type

  • 8.1. Monitor Console
  • 8.2. Portable Handheld Device
  • 8.3. Sensor Probe

9. Transcutaneous CO2 Monitoring Market, by Technology

  • 9.1. Electrochemical
  • 9.2. Optical

10. Transcutaneous CO2 Monitoring Market, by Age Group

  • 10.1. Adults
  • 10.2. Neonates
  • 10.3. Pediatrics

11. Transcutaneous CO2 Monitoring Market, by Application

  • 11.1. Ambulatory Monitoring
    • 11.1.1. Cardiopulmonary Rehabilitation
    • 11.1.2. Outpatient Monitoring
  • 11.2. Intensive Care
    • 11.2.1. Adult Intensive Care
    • 11.2.2. Neonatal Intensive Care
    • 11.2.3. Pediatric Intensive Care
  • 11.3. Neonatal Care
    • 11.3.1. Preterm Neonatal Care
    • 11.3.2. Term Neonatal Care
  • 11.4. Respiratory Care
    • 11.4.1. Acute Respiratory Care
    • 11.4.2. Chronic Respiratory Care

12. Transcutaneous CO2 Monitoring Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Clinics
    • 12.2.1. General Clinics
    • 12.2.2. Specialty Clinics
  • 12.3. Home Healthcare
    • 12.3.1. Home Nursing Services
    • 12.3.2. Telemonitoring Services
  • 12.4. Hospitals
    • 12.4.1. Secondary Care Hospitals
    • 12.4.2. Tertiary Care Hospitals

13. Transcutaneous CO2 Monitoring Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Transcutaneous CO2 Monitoring Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Transcutaneous CO2 Monitoring Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Transcutaneous CO2 Monitoring Market

17. China Transcutaneous CO2 Monitoring Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Baxter International Inc.
  • 18.6. Becton, Dickinson and Company
  • 18.7. Dragerwerk AG & Co. KGaA
  • 18.8. General Electric Company
  • 18.9. Koninklijke Philips N.V.
  • 18.10. Laike Biotechnology Co., Ltd.
  • 18.11. Masimo Corporation
  • 18.12. Medicap GmbH
  • 18.13. Medtronic plc
  • 18.14. Mindray DS USA, Inc.
  • 18.15. Nihon Kohden Corporation
  • 18.16. Nonin Medical, Inc.
  • 18.17. Perimed AB
  • 18.18. Philips Healthcare
  • 18.19. Qiumanshi Medical Technology Co., Ltd.
  • 18.20. Radiometer A/S
  • 18.21. Sentec AG
  • 18.22. Shinsei Electronics Corporation
  • 18.23. Smiths Group plc
  • 18.24. Welch Allyn Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY MONITOR CONSOLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY MONITOR CONSOLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY MONITOR CONSOLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PORTABLE HANDHELD DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PORTABLE HANDHELD DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PORTABLE HANDHELD DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SENSOR PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SENSOR PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SENSOR PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ELECTROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ELECTROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CARDIOPULMONARY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CARDIOPULMONARY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CARDIOPULMONARY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OUTPATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OUTPATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OUTPATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULT INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULT INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULT INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRIC INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRIC INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRIC INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRETERM NEONATAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRETERM NEONATAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRETERM NEONATAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERM NEONATAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERM NEONATAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERM NEONATAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ACUTE RESPIRATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ACUTE RESPIRATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ACUTE RESPIRATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CHRONIC RESPIRATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CHRONIC RESPIRATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CHRONIC RESPIRATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME NURSING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME NURSING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME NURSING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TELEMONITORING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TELEMONITORING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TELEMONITORING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 226. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 232. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 271. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 274. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 277. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 284. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 285. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 286. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 287. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 290. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET